Faculty profile

Lawson Eng

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Toronto

Lawson Eng

Assistant Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
49 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Acute Care Use Cancer Geriatric Oncology Immunotherapy Older Adults Outcomes Research Predictive Modelling Statistical Machine Learning

Latest papers

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
Decisional regret in oncology: a scoping review.
BMJ supportive & palliative care · 2026
Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.
JTO clinical and research reports · 2026

All 88 publications

Latest funding

Understanding the impact of age and frailty on immune checkpoint inhibitor (ICI) outcomes in cancer patients
CIHR · 2024 · Nominated PI
$153,000
Understanding the impact of age and frailty on immune checkpoint inhibitor (ICI) outcomes in cancer patients
CIHR · 2024 · Nominated PI
$25,000
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
CIHR · 2023 · Co-investigator
$929,475

All 4 grants and awards

88 publications.

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Rühle A, Sanz-Garcia E, Su J, O'Sullivan B, Waldron JN, Spreafico A, Siu L, Eng L, McPartlin A, Bayley A, Bratman SV, Hahn E, Hope A, Hosni A, Malik N, Tsai J, de Almeida J, Xu W, Kim J, Huang SH

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111769 PMID: 42697275

Decisional regret in oncology: a scoping review.

Halladay L, Hatolkar V, Malik H, Zhao L, Boldt G, Lock M, Simone CB, Eng L, Leigh J, Zimmermann C, Bruera E, Chow R

BMJ supportive & palliative care2026

DOI: 10.1136/spcare-2026-006384 PMID: 42772893

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

Fan ZJ, Tudor R, Cabanero M, Le LW, Rabey M, Law JH, Stockley T, Kuang S, Meti N, Fung A, Perdrizet K, Chen K, Li JJN, Ghumman N, Ranich L, Wei C, Sabatini P, Pal P, Hsu YR, Ko HM, Schwock J, Tsao MS, Liu G, Shepherd FA, Bradbury P, Sacher A, Eng L, Leighl NB

JTO clinical and research reports2026

DOI: 10.1016/j.jtocrr.2026.101012 PMID: 42529245

Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis.

Chow R, Zhang D, Chai GW, Yuen M, Lu A, Fortuna V, Talwar S, Boldt G, Lock M, Lee SF, Eng L, Iihara H, Affronti ML, Saito M, Aapro M, Hesketh PJ, Scotté F, Ruhlmann CH, Leigh J, MASCC Antiemetic Study Group

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

DOI: 10.1007/s00520-026-10944-z PMID: 42461312

Prevalence of antibody drug conjugated-induced nausea and vomiting (ADCINV) in patients with cancer.

Chow R, Zhang D, Kannout S, Ma A, Zheng C, Blayne A, Dou A, Talwar S, Fazelzad R, Rugo HS, Ruhlmann CH, Iihara H, Affronti ML, Leigh J, Scotté F, Eng L, MASCC Antiemetic Study Group and the MASCC Emerging Toxicities Study Group

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026Senior author

DOI: 10.1007/s00520-026-10674-2 PMID: 42068413

Impact of age and frailty on acute care use during immune checkpoint inhibitor treatment.

Eng L, Faour E, Sutradhar R, Kaliwal Y, Niu Y, Liu N, Liu Y, Powis M, Liu G, Peppercorn JM, Krzyzanowska MK, Alibhai SMH

Journal of the National Cancer Institute2026First author

DOI: 10.1093/jnci/djaf373 PMID: 41452749

Implementation of electronic patient-reported outcomes in supportive care for oncology patients.

Gomes Siqueira LBM, Callens D, Choi S, Benazzouz C, Lan X, Dunphy C, Howell D, Eng L, Oldenburger E

Current opinion in supportive and palliative care2026

DOI: 10.1097/spc.0000000000000793 PMID: 41549860

Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.

Sanz-Garcia E, Soleimani S, Bruce JP, Pedersen S, Tang M, Avery L, Eagles J, Spreafico A, Hansen AR, Eng L, Laliotis G, Krainock M, Liu M, Basra P, Yu C, Felicen S, Ohashi PS, Bratman SV, Pugh TJ, Siu LL

Clinical cancer research : an official journal of the American Association for Cancer Research2026

DOI: 10.1158/1078-0432.ccr-25-3541 PMID: 41417470

Weight, BSA, Toxicity, and Efficacy of Tyrosine Kinase Inhibitors for ALK-Mutated NSCLC.

Munarriz BJ, Khan S, Hueniken K, Tam S, Patel D, Zhan L, Brown C, Eng L, Sacher A, Bradbury P, Leighl N, Liu G, Shepherd FA

JTO clinical and research reports2026

DOI: 10.1016/j.jtocrr.2025.100918 PMID: 41479841

Opening Move: When to Lead With Systemic Therapy in Synchronous Oligometastatic Anal Cancer.

Siqueira LBMG, Eng L

International journal of radiation oncology, biology, physics2026Senior author

DOI: 10.1016/j.ijrobp.2025.09.032 PMID: 41391919

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Lawson Eng

Research

Latest papers

Latest funding

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Decisional regret in oncology: a scoping review.

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

Olanzapine (10&#xa0;mg vs 5&#xa0;mg vs 2.5&#xa0;mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis.

Prevalence of antibody drug conjugated-induced nausea and vomiting (ADCINV) in patients with cancer.

Impact of age and frailty on acute care use during immune checkpoint inhibitor treatment.

Implementation of electronic patient-reported outcomes in supportive care for oncology patients.

Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.

Weight, BSA, Toxicity, and Efficacy of Tyrosine Kinase Inhibitors for ALK-Mutated NSCLC.

Opening Move: When to Lead With Systemic Therapy in Synchronous Oligometastatic Anal Cancer.

Understanding the impact of age and frailty on immune checkpoint inhibitor (ICI) outcomes in cancer patients

Understanding the impact of age and frailty on immune checkpoint inhibitor (ICI) outcomes in cancer patients

Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer

Supporting older adults with cancer and their support person through geriatric assessment and remote exercise and education: the SOAR study

Frequent collaborators

Geoffrey Liu

Wei Xu

Doris Howell

Peter Selby

Adrian Sacher

Andrew Hope

Anna Spreafico

Osvaldo Espin Garcia

Fei-Fei Liu

William Evans

John Kim

Nicole Mittmann

Janet Papadakos

John de Almeida

Enrique Sanz Garcia

Meredith Giuliani

Camilla Zimmermann

Rinku Sutradhar

Rosemary Martino

Jennifer Croke

Sevtap Savas

Ning Liu

Jackie Bender

Madeline Li

Monika Krzyzanowska

Lillian Siu

Tracy Stockley

Mandana Vahabi

Elliot Wakeam

Ian Witterick

Lisa Avery

Marcus Law

Philip Wong

Michael Yan

Robert Grant

Melanie Powis

Karen Leslie

Martine Puts

Hans Katzberg

Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis.